B Cell Immunology for Protective HIV-1 Vaccines (U01)

The summary for the B Cell Immunology for Protective HIV-1 Vaccines (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
B Cell Immunology for Protective HIV-1 Vaccines (U01): -Purpose. The goal of this Funding Opportunity Announcement (FOA) is to support high impact basic immunology studies and innovative methods that may lead to induction of broadly reactive, neutralizing antibodies that can prevent infection by a wide spectrum of clinically relevant HIV-1 virus strains. Identifying approaches that induce effective and broadly neutralizing antibodies is a priority of the Global HIV/AIDS Vaccine Enterprise (http://medicine.plosjournals.org/perlserv/?request=get-document and doi=10.1371/journal.pmed.0020025). This program will create new collaborative research enterprises focused on a key parameter for HIV-1 vaccine development: defining the basic immune mechanisms by which an effective and robust neutralizing antibody response can be elicited in uninfected individuals to protect against a broad range of HIV-1 strains. This U01 cooperative agreement grant program will support basic immunology research on B cell and antibody regulation. Clinical trials will not be supported by this FOA. -Mechanism of Support. This FOA will utilize the U01 grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-AI-07-015, that solicits applications under the R21 mechanism. -Funds Available and Anticipated Number of Awards. It is anticipated that $2.5 million will be available for this FOA and that 4-5 new awards will be made. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: B Cell Immunology for Protective HIV-1 Vaccines (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-07-014
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.85593.856
CFDA Descriptions: Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jun 30, 2007
Posted Date: Mar 13, 2007
Creation Date: Mar 13, 2007
Archive Date: Jul 30, 2007
Total Program Funding: $2,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Special district governments Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts City or township governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster